A benefit–harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions-Reference-Cited by-同舟云学术

A benefit–harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions

Published:2019-09 Issue: Volume:113 Page:92-100
ISSN:0895-4356
Container-title:Journal of Clinical Epidemiology
language:en
Short-container-title:Journal of Clinical Epidemiology

Author:

Bennett Wendy L.^ORCID,Aschmann Hélène E.,Puhan Milo A.,Robbins Craig W.,Bayliss Elizabeth A.^ORCID,Wilson Renee,Mularski Richard A.,Chan Wiley V.^ORCID,Leff Bruce,Sheehan Orla,Glover Carol,Maslow Katie,Armacost Karen^ORCID,Mintz Suzanne,Boyd Cynthia M.

Publisher

Elsevier BV

Subject

Epidemiology

Reference35 articles.

1. Global multimorbidity patterns: a cross-sectional, population-based, multi-country study;Garin;J Gerontol A Biol Sci Med Sci,2016

2. Age and gender differences in the prevalence and patterns of multimorbidity in the older population;Abad-Diez;BMC Geriatr,2014

3. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study;Barnett;Lancet,2012

4. Multimorbidity patterns in the United States: implications for research and clinical practice;Goodman;J Gerontol A Biol Sci Med Sci,2016

5. Patterns of prevalent major chronic disease among older adults in the United States;Weiss;JAMA,2007

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of Glycated Hemoglobin in Total Hemoglobin by a Simultaneous Dual-Signal Acquisition Approach;ACS Sensors;2024-04-05

2. The rise of best-worst scaling for prioritization: A transdisciplinary literature review;Journal of Choice Modelling;2024-03

3. Effects of combined metformin and cabergoline versus metformin alone on ovarian and hormonal activities in Iraqi patients with PCOS and hyperprolactinemia: a randomized clinical trial;Journal of Medicine and Life;2023-11

4. The Potential of SGLT-2 Inhibitors in the Treatment of Polycystic Ovary Syndrome: The Current Status and Future Perspectives;Biomedicines;2023-03-23

5. Best-worst scaling preferences among patients with well-controlled epilepsy: Pilot results;PLOS ONE;2023-03-03